article thumbnail

ACR updates Manual on Contrast Media

AuntMinnie

The American College of Radiology (ACR) has published the 2024 edition of its Manual on Contrast Media.

article thumbnail

How AI is Transforming the Pharmaceutical Industry

MRI Network

It’s also primed to revolutionize the pharmaceutical industry. This is where MRI Network recruiters focused on the pharmaceutical industry come into play. Generative AI systems can also track company leadership and researchers responsible for key decisions from program initiation to completion.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Quibim’s QP-Prostate cleared for diagnosing prostate cancer

AuntMinnie

Food and Drug Administration (FDA) for the use of its QP-Prostate MRI software to help detect and diagnose prostate cancer. hospitals and pharmaceutical companies and that QP-Prostate was initially cleared in 2021 for automated segmentation of prostate regions. Quibim has received clearance from the U.S.

Diagnose 130
article thumbnail

Early Mover’s Advantage: Why Al Lerberg Chose Cybersecurity Recruiting Before It Exploded [Replay]

MRI Network

Guest Bio Al Lerberg founded MRI of Elk River in the fall of 2009 after MRI boot camp in Cleveland Ohio. Originally started as an executive recruiting firm focused on the pharmaceutical industry, it quickly evolved into an IT recruiting firm with a strong focus on Cyber Security.

IT 52
article thumbnail

AuntMinnie 2017: Pull linear MRI contrast from market, European group says

AuntMinnie

In a stunning development, a European Union regulatory body on March 10 recommended that four gadolinium-based contrast agents (GBCAs) for MRI scans be pulled off the market due to concerns about gadolinium remaining in the body years after scans occur.

MRI 147
article thumbnail

PET tracer for gliomas under expedited review

AuntMinnie

Food and Drug Administration (FDA) has granted fast-track designation to Telix Pharmaceuticals’ PET radiotracer F-18 floretyrosine (Pixclara) for imaging progressive or recurring gliomas. Pixclara was developed by researchers at the University of California, San Francisco.

article thumbnail

Immunis Partners with Springbok Analytics on MRI-based AI Muscle Analysis Technology

Imaging Technology

Springbok is building a new standard in muscle health with its MRI-based AI muscle analysis technology that is used widely throughout elite sports, human performance and life sciences. Sarcopenia is an inevitable symptom of aging, and yet there are no pharmaceutical interventions to prevent or address the issue.

MRI 104